NCT01725646View on ClinicalTrials.gov

An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
Hypertriglyceridemia
Interventions
DRUG

Omacor®

Subjects in 4 g and 2 g Omacor® will take this drug

DRUG

Placebo

Subjects in placebo group will take this drug

Trial Locations (4)

100

National Taiwan University Hospital, Taipei

704

National Cheng Kung University Hospital, Tainan City

11217

Taipei Veterans General Hospital, Taipei

40705

Taichung Veterans General Hospital, Taichung

Sponsors

Lead Sponsor

Excelsior
All Listed Sponsors
lead

Excelsior

INDUSTRY